What condition can be caused by Viracept (nelfinavir)?

What condition can be caused by Viracept (nelfinavir)?

• A. Kidney stones
• B. Hepatotoxicity
• C. Fat redistribution
• D. Osteoporosis

Answer: (A)

Viracept (nelfinavir) is an antiretroviral medication used primarily for the treatment of HIV infection. Among the known side effects of nelfinavir, fat redistribution is a notable condition. It refers to the phenomenon where patients experience changes in body fat distribution, leading to increased fat in certain areas of the body and loss in others. This can result in a characteristic appearance often described as "lipodystrophy." While kidney stones can occur with various medications and conditions, they are not a well-documented or common side effect associated specifically with nelfinavir. Hepatotoxicity, or liver damage, is also a potential side effect of many medications but specific studies and data show more direct association of fat redistribution with Viracept. Thus, in light of these considerations, fat redistribution is the side effect that aligns with the pharmacological profile and clinical data of Viracept, making it an important aspect of its potential adverse effects worth understanding for those undergoing treatment.

Viracept (nelfinavir) is an antiretroviral medication used primarily for the treatment of HIV infection. Among the known side effects of nelfinavir, fat redistribution is a notable condition. It refers to the phenomenon where patients experience changes in body fat distribution, leading to increased fat in certain areas of the body and loss in others. This can result in a characteristic appearance often described as "lipodystrophy."

While kidney stones can occur with various medications and conditions, they are not a well-documented or common side effect associated specifically with nelfinavir. Hepatotoxicity, or liver damage, is also a potential side effect of many medications but specific studies and data show more direct association of fat redistribution with Viracept.

Thus, in light of these considerations, fat redistribution is the side effect that aligns with the pharmacological profile and clinical data of Viracept, making it an important aspect of its potential adverse effects worth understanding for those undergoing treatment.